ROLLINS INC annual report, FY2020

Rollins, Inc. 2020 Form 10-K Summary

Reporting period: Fiscal year ended December 31, 2020. The filing is an annual report, not a standalone fourth-quarter filing. Rollins provides residential and commercial pest and termite control services through wholly owned subsidiaries and franchises across the United States and international markets. The company reports one segment: pest and termite control.

Key Financial Metrics

Metric20202019Change
Revenue$2.161 billion$2.015 billion+7.2%
Income before taxes$354.7 million$261.2 million+35.8%
Net income$260.8 million$203.3 million+28.3%
Diluted EPS$0.53$0.41+29.3%
Net profit margin12.1%10.1%+2.0 percentage points
Gross margin51.5%50.7%+0.8 percentage points
Operating cash flow$435.8 million$319.6 million+36.4%
Capital expenditures$23.2 million$27.1 millionLower
Cash and equivalents$98.5 million$94.3 million+4.5%
Total debt$203.0 million$291.5 million-$88.5 million
Dividends paid$160.5 million$153.8 millionHigher

Revenue growth was led by residential pest control, up 13.4%, and termite and ancillary revenue, up 9.6%. Commercial revenue declined 0.5% due to COVID-19-related shutdowns. Revenue mix was approximately 45% residential, 36% commercial, and 19% termite and ancillary services. Approximately 80% of pest-control revenue was recurring.

Gross-margin expansion reflected lower service-wage growth, improved routing and scheduling efficiency, and lower fuel prices. SG&A declined to 30.4% of revenue from 30.9%. Depreciation and amortization increased to $88.3 million from $81.1 million, and the effective tax rate rose to 26.5% from 22.1%.

Liquidity, Debt and Cash Flow

  • Operating activities generated $435.8 million of cash; investing activities used $162.4 million; financing activities used $281.3 million.
  • Acquisition cash spending was $147.6 million, compared with $430.6 million in 2019. The company completed 31 acquisitions, including McCall Pest Management, remaining Clark Pest Control locations, Adam’s Pest Control in Australia, and other smaller businesses.
  • At year-end, debt consisted of $67.0 million drawn under a $175.0 million revolving facility and $136.0 million under a term loan. The effective interest rate was 1.07%.
  • The company was in compliance with its 3.00-to-1.00 leverage covenant and expected to remain compliant throughout 2021.
  • Management stated that cash, expected operating cash flow, and available borrowing capacity were sufficient for operations, obligations, and planned expansion.
  • Planned 2021 capital expenditures were $25 million to $30 million.
  • Contractual obligations totaled $472.7 million, including debt, acquisition holdbacks and earnouts, operating leases, and unrecognized tax positions.

Material Changes Versus 2019

  • Revenue, pretax income, net income, EPS, margins, and operating cash flow all increased materially.
  • Commercial operations weakened during the pandemic, while residential demand benefited from sheltering and work-from-home trends.
  • The company forgave its normal mid-year price increase, which historically contributes approximately 1% to annual revenue growth.
  • Debt declined by $88.5 million after net repayments, while cash increased modestly.
  • Acquisition activity decreased substantially from 2019, when the company acquired Clark Pest Control.
  • The company recorded $6.7 million of accelerated stock-vesting expense in 2020; no comparable expense occurred in 2019.
  • The $49.9 million pension settlement loss recorded in 2019 did not recur in 2020, contributing to the year-over-year profit improvement.
  • The company adopted the current expected credit-loss standard, producing a $2.5 million increase to beginning retained earnings.
  • A three-for-two stock split became effective December 10, 2020; all share and per-share data were retroactively adjusted.
  • No open-market share repurchases occurred in 2020 or 2019. The company repurchased $8.3 million of shares from employees for tax withholding and retained authorization to repurchase 11.4 million shares.

Guidance, Outlook and Management Commentary

  • Management expected COVID-19 pressure on commercial customers to persist through much of 2021 until broader vaccination reduced disruption.
  • Management did not anticipate a significant long-term revenue or cash-flow decline sufficient to impair goodwill or indefinite-lived intangible assets; the 2020 impairment analysis identified no impairment.
  • The company intends to continue pursuing acquisitions, international expansion, and Orkin franchise growth.
  • The company expected to continue paying cash dividends, subject to earnings, financial condition, and other relevant factors. A regular quarterly dividend of $0.08 per share was declared in January 2021.
  • Management did not expect a contribution to the remaining pension plan in 2021. Approximately $1.2 million of excess assets from the settled pension plan remained and could revert to the company under ERISA requirements.

Risks, Contingencies and Unusual Items

  • SEC investigation: The SEC investigation remained ongoing and focused primarily on period-end accruals and reserves beginning in 2015. An internal investigation concluded in October 2020 and identified a significant deficiency in documentation and review of certain reserve and accrual entries. Management reported that remediation had been completed, but potential sanctions, litigation, additional remedial measures, and reputational effects remained uncertain.
  • COVID-19: Further resurgences, government restrictions, commercial customer closures, supply-chain disruption, and changing customer retention could affect results and estimates.
  • Estimation risk: Accrued insurance, termite claims, credit losses, litigation reserves, goodwill, and intangible assets depend on assumptions that could differ from actual outcomes. Accrued insurance was also identified as the critical audit matter.
  • Regulation and litigation: The company faces environmental, worker-safety, consumer-protection, privacy, telemarketing, employment, franchise, and other regulatory requirements, as well as ordinary-course claims and disputes.
  • Labor and competition: Tight labor markets, wage inflation, employee retention, pricing pressure, and competition from Terminix, Ecolab, Rentokil, Anticimex, and smaller providers could pressure margins and growth.
  • Other risks: Cybersecurity incidents, adverse weather, foreign exchange, international expansion, acquisition integration, franchisee conduct, product or service liability, and insurance coverage limitations could materially affect results.
  • Ownership structure: Executive officers, directors, and affiliates controlled approximately 54% of outstanding shares and the company qualified as a controlled company under NYSE rules.

Investor Verification Checklist

  • Verify the status, scope, and potential financial or regulatory consequences of the ongoing SEC investigation.
  • Assess whether commercial revenue and customer retention recovered as COVID-19 restrictions eased.
  • Reconcile acquisition spending, goodwill growth to $653.2 million, and integration performance.
  • Review debt maturities, revolving-facility availability, covenant compliance, interest-rate exposure, and the $35.1 million of letters of credit.
  • Evaluate the adequacy of accrued insurance, termite claims, credit-loss reserves, and other accounting estimates.
  • Confirm the sustainability of dividends and future acquisition spending relative to operating cash flow.
  • Review the effect of the three-for-two split and executive and affiliate ownership on per-share analysis and governance.